A Partnership Initiative for HIV Prevention Trials
艾滋病毒预防试验合作倡议
基本信息
- 批准号:7878544
- 负责人:
- 金额:$ 54.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-11 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAIDS/HIV problemAddressAfrican AmericanAgeAttitudeBehaviorCollaborationsCommunitiesCommunity SurveysCreativenessData CollectionDiscriminationEducational CurriculumEnsureEthnographyEvaluationFocus GroupsFosteringFutureGroup AffiliationHIV prevention trialInterviewMapsMeasuresModelingParticipantPoliciesPopulationPrevention programProblem SolvingProcessProphylactic treatmentResearchResearch DesignResearch MethodologyResearch PersonnelRespondentRiskSamplingStructureSurveysTechnologyTrustUnited StatesVaccinescommunity based participatory researcheffective interventionexperiencehealth disparityimprovedliteracymicrobicideprogramspublic health relevancesuccesstheories
项目摘要
DESCRIPTION (provided by applicant): The proposed research addresses a critical question for the future success of vaccine, microbicide, pre-exposure prophylaxis and other emerging HIV prevention technologies in the United States: How can we ensure that the community support and program capacity to evaluate and deliver new HIV prevention technologies are available where they are most needed? The research setting (Durham, NC) provides an ideal context to conduct research to address this question. The 5-year study will evaluate a systematic partnership-building approach for HIV prevention trial planning and implementation. The research aims are three-fold. AIM 1 is to implement and conduct a process evaluation of a systematic community-based participatory research model to build support for new HIV prevention technologies in the African American community. This is accomplished through use of a conceptual framework that (1) integrates research with policy, community, behavior, and programs; (2) builds on community-based participatory research principles; (3) uses ethnography to generate empirical evidence to inform research design and provide a bridge between local residents, the research team, and other stakeholder groups; and (4) draws on group theory to refine the structure of stakeholder involvement and foster inclusiveness, creativity and active problem-solving. AIM 2 is to describe the communities and group affiliations that exist among young (ages 18-30) at-risk African Americans, and measure the relationship among experiences of discrimination, levels of trust, and support for new HIV prevention technologies in this population. AIM 3 is to identify priorities for evaluating and implementing new HIV prevention technologies in the African American community. Research methods include participant observation, ethnographic mapping, focus groups, semi-structured interviews, and quantitative surveys. An HIV prevention technologies research literacy curriculum will be developed, implemented and evaluated; the evaluation will include an assessment of community attitudes toward research on specific HIV prevention technologies. Support for and feasibility of collaboration in conducting local research on new HIV prevention technologies will assessed with multiple stakeholder groups including researchers. Across all years a two-way process evaluation of the evolving community partnership will be undertaken. Sampling strategies include respondent-driven sampling for a community survey of young at-risk African Americans in Years 2 and 3; purposive sampling will be used for all other data collection activities. The results of all data collection activities will be presented to community partners and guidance solicited for next steps in evaluating and delivering new HIV prevention technologies.
PUBLIC HEALTH RELEVANCE: African Americans experience significant health disparities and this is especially evident with regard to HIV/AIDS in the U.S. South. Improving the capacity for HIV prevention trials in partnership with African American communities will lay the groundwork for moving effective interventions into successful prevention programs.
描述(由申请人提供):拟议的研究解决了疫苗,杀微生物剂,暴露前预防和其他新兴的艾滋病毒预防技术在美国未来成功的一个关键问题:我们如何确保社区的支持和计划能力,以评估和提供新的艾滋病毒预防技术是最需要的?研究设置(达勒姆,北卡罗来纳州)提供了一个理想的背景下进行研究,以解决这个问题。这项为期5年的研究将评估艾滋病毒预防试验规划和实施的系统性伙伴关系建设方法。研究目标有三个方面。目标1是对一个系统的以社区为基础的参与性研究模式实施和进行过程评价,以支持非洲裔美国人社区的艾滋病毒预防新技术。这是通过使用一个概念框架来实现的,该框架(1)将研究与政策,社区,行为和计划相结合;(2)建立在基于社区的参与性研究原则之上;(3)使用人种学来产生经验证据,为研究设计提供信息,并在当地居民,研究团队和其他利益相关者群体之间提供桥梁;及(4)借鉴群体理论,优化持份者参与的结构,并促进包容性、创造性和积极解决问题的能力。目的2是描述存在于年轻(18-30岁)处于危险中的非洲裔美国人之间的社区和群体关系,并衡量这一人群中歧视经历,信任程度和对新的艾滋病毒预防技术的支持之间的关系。目标3是确定在非裔美国人社区评价和实施新的艾滋病毒预防技术的优先事项。研究方法包括参与观察、民族志绘图、焦点小组、半结构化访谈和定量调查。将制定、实施和评价艾滋病毒预防技术研究扫盲课程;评价将包括评估社区对具体艾滋病毒预防技术研究的态度。将与包括研究人员在内的多个利益攸关方群体一起评估在开展新的艾滋病毒预防技术的地方研究方面开展合作的支持和可行性。在所有年份中,将对不断发展的社区伙伴关系进行双向评估。抽样策略包括在第2年和第3年对处于风险中的年轻非洲裔美国人进行社区调查时采用受访者驱动抽样;所有其他数据收集活动将采用有目的抽样。所有数据收集活动的结果都将提交给社区合作伙伴,并为评价和提供新的艾滋病毒预防技术的下一步骤征求指导。
公共卫生关系:非裔美国人经历了显著的健康差距,这在美国南部的艾滋病毒/艾滋病方面尤为明显。与非裔美国人社区合作,提高艾滋病毒预防试验的能力,将为将有效的干预措施转化为成功的预防方案奠定基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kathleen M MacQueen其他文献
Framing the social in biomedical HIV prevention trials: a 20-year retrospective
- DOI:
10.1186/1758-2652-14-s2-s3 - 发表时间:
2011-09-01 - 期刊:
- 影响因子:4.900
- 作者:
Kathleen M MacQueen - 通讯作者:
Kathleen M MacQueen
Kathleen M MacQueen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kathleen M MacQueen', 18)}}的其他基金
PrEP Connect: Bridging HIV Testing to PrEP Screening and Uptake
PrEP 连接:将 HIV 检测与 PrEP 筛查和吸收联系起来
- 批准号:
10249338 - 财政年份:2020
- 资助金额:
$ 54.74万 - 项目类别:
PrEP Connect: Bridging HIV Testing to PrEP Screening and Uptake
PrEP 连接:将 HIV 检测与 PrEP 筛查和吸收联系起来
- 批准号:
10079952 - 财政年份:2020
- 资助金额:
$ 54.74万 - 项目类别:
Developing a Theory of Change for Evaluating Participatory Practices in TB Trials
发展变革理论来评估结核病试验中的参与实践
- 批准号:
8602605 - 财政年份:2013
- 资助金额:
$ 54.74万 - 项目类别:
A Partnership Initiative for HIV Prevention Trials
艾滋病毒预防试验合作倡议
- 批准号:
8084115 - 财政年份:2008
- 资助金额:
$ 54.74万 - 项目类别:
A Partnership Initiative for HIV Prevention Trials
艾滋病毒预防试验合作倡议
- 批准号:
8289332 - 财政年份:2008
- 资助金额:
$ 54.74万 - 项目类别:
A Partnership Initiative for HIV Prevention Trials
艾滋病毒预防试验合作倡议
- 批准号:
7494918 - 财政年份:2008
- 资助金额:
$ 54.74万 - 项目类别:
A Partnership Initiative for HIV Prevention Trials
艾滋病毒预防试验合作倡议
- 批准号:
7728106 - 财政年份:2008
- 资助金额:
$ 54.74万 - 项目类别:
A Partnership Initiative for HIV Prevention Trials
艾滋病毒预防试验合作倡议
- 批准号:
7686221 - 财政年份:2008
- 资助金额:
$ 54.74万 - 项目类别:
UNC Center for AIDS Research Core B Developmental
北卡罗来纳大学艾滋病研究中心核心 B 发展
- 批准号:
10404029 - 财政年份:2001
- 资助金额:
$ 54.74万 - 项目类别:
UNC Center for AIDS Research Core B Developmental
北卡罗来纳大学艾滋病研究中心核心 B 发展
- 批准号:
10840662 - 财政年份:2001
- 资助金额:
$ 54.74万 - 项目类别:














{{item.name}}会员




